After the whole Axiron caper blew up on them, it took a while...

After the whole Axiron caper blew up on them, it took a while before they were able to get going on a new direction with these generic drugs. I knew at the time that they were being too hopeful with the timeline for approvals but I thought to myself that if I wait out the drug development time the sp will recover. I was of the view that the biggest hurdle was the approvals with the FDA (as it was out of our control)

I never thought the following:-

1. Very low royalties from Evamist/Lenzetto after 1 decade on the market (yes 1 decade) . I had assumed this would grow steadily during the product development.

2. Commercialization of approved products now dragging very badly.

3. They would partner with bankrupts.

5. Economics of the approved products looking dodgy (surely they must have thought about this before beginning work on them??).

4. Cash burn still enormous.

The company is now in a world of pain.

They took twice as long as they should have to get the approvals. Now they appear to be taking twice as long as they should to commercialize also (maybe commercial partners are down grading priority if the products are low value??).

Now I am the fool that invested with them - no question.

But is it not reasonable for me to expect some kind of performance (even an average performance) in getting these products generating revenue?

I am pissed off.